KBL Merger Corp. IV (KBLM), filed a definitive proxy this evening for their upcoming extension vote on April 8th, to extend their deadline from April 9, 2020 to July 9, 2020. However, KBLM is offering a very, very attractive $55,000 per month contribution to trust for non-redeeming shareholders, which equates to, at a minimum (assuming no one redeems) $0.049 per share per month, up to a maximum of $0.099 per month…for three months.
So let’s assume the maximum amount of shareholders redeem and everyone who didn’t redeem is entitled to $0.099 per month. That means those shareholders are entitled to receive $0.297 total if all three months are needed for KBLM to complete their combination with CannBioRx. Which, in the current climate, an additional three months is not that out of the realm of possibility. There are only 1,114,267 SPAC shares left currently outstanding, but with a very juicy contribution to trust, this should definitely make any potential redeemers pause and reconsider.
One important note: in order to redeem you MUST be a shareholder of record, of which, the record date is March 12, 2020. So, if you bought KBLM’s shares and they settled after March 12th, you cannot vote and therefore, cannot be eligible to redeem.
Bottom line, preservation of cash is important and the Coronavirus is cashing in chits…going to make teams pay one way or another.
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...